| Bioactivity | Protein Kinase C (530-558), a peptide fragment of protein kinase C (PKC), is a potent PKC activator. Protein Kinase C (530-558) significantly inhibits osteoclastic bone resorption[1]. |
| Invitro | Protein Kinase C (530-558) (1 nM-1 μM, 24 h) causes a dose-responsive inhibition of bone resorption, which is accompanied by a rapid and distinctive change in osteoclast morphology[1]. Cell Viability Assay[1] Cell Line: |
| Name | Protein Kinase C (530-558) |
| CAS | 122613-29-0 |
| Shortening | LLYEMLAGQAPFEGEDEDELFQSIMEHNV |
| Formula | C148H221N35O50S2 |
| Molar Mass | 3354.67 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Protein Kinase C (530-558)
CAS: 122613-29-0 F: C148H221N35O50S2 W: 3354.67
Protein Kinase C (530-558), a peptide fragment of protein kinase C (PKC), is a potent PKC activator. Protein Kinase C (5
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.